
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Edity is developing a novel delivery platform that uses immune cells to transfer therapeutic proteins to the target cells of patients. Our technology allows for precise modulation of intracellular pathways of disease using a range of proteins including gene editors, immune sensors, enzymes and intrabodies
Gene editing,cell therapy,gene therapy,drug delivery,and cancer
Edity therapeutics operates in the Biotechnology research industry.
Edity therapeutics's revenue is 11m - 100m
Edity therapeutics has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.